Filter
750
Filtered Results: 750
Text search:
drug
dosing
Featured
Recommendations
104
New Publications
198
Language
Document type
No document type
435
Guidelines
160
Studies & Reports
82
Manuals
25
Training Material
16
Fact sheets
14
Strategic & Response Plan
10
Situation Updates
3
Resource Platforms
3
App
1
Online Courses
1
Countries / Regions
India
49
South Africa
34
Kenya
24
Tanzania
22
Ethiopia
18
Global
16
Zambia
14
Uganda
12
Africa
12
Rwanda
11
Nepal
10
Nigeria
8
Ghana
8
Namibia
8
Sierra Leone
7
Malawi
7
Western and Central Europe
7
Zimbabwe
6
Bangladesh
6
Myanmar / Burma
6
Philippines
5
Liberia
4
USA
4
South Sudan
4
Cambodia
4
Eswatini/ Swaziland
3
Lesotho
3
Latin America and the Carribbean
3
Congo, Democratic Republic of
2
Syria
2
Argentina
2
Ukraine
2
Botswana
2
West and Central Africa
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Asia
2
Burkina Faso
1
Cameroon
1
Haiti
1
Pakistan
1
Iraq
1
Germany
1
Thailand
1
Gambia
1
Indonesia
1
Sudan
1
Benin
1
Brazil
1
Angola
1
East and Southern Africa
1
Western Pacific Region
1
Venezuela
1
Eastern Europe
1
Albania
1
Canada
1
Tajikistan
1
Russia
1
Georgia
1
North America
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
252
Clinical Guidelines
153
Women & Child Health
41
Public Health
26
Capacity Building
21
Key Resources
3
Pharmacy & Technologies
3
Annual Report MEDBOX
1
Toolboxes
HIV
112
TB
86
AMR
67
Mental Health
35
Pharmacy
35
COVID-19
25
NTDs
20
NCDs
20
Caregiver
12
Ebola
9
Conflict
6
Rapid Response
6
Refugee
5
Cholera
4
Planetary Health
4
Polio
3
Specific Hazards
2
Health Financing Toolbox
2
Disability
1
Version 10.1_5 October 2020
These Guidelines are available in different formats: As a paper booklet, a PDF, a mobile app, and now also as a website.
The 2019 version of the Guidelines introduces a new drug-... interaction panel and now consists of six main sections, including a general overview table of all major issues in PLWH, recommendations on antiretroviral treatment, drug-drug interactions, diagnosis, monitoring and treatment of co-morbidities, co-infections and opportunistic diseases.
Available in English, French, Spanish, German, Portuguese, Russian, Chinese and Japanese
These guidelines are based on the 3rd Edition of the WHO Guidelines (Published 2015) World Health Organization’s Guidelines for the treatment of malaria. Additional literature surveys have been undertaken. Factors that were considered in the choice of therapeutic options included effectiveness, sa...
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand...
The extensive use of antimicrobials in human and veterinary medicine in recent years has accelerated the emergence and spread of resistant microorganisms. This situation has been worsened by the lack of investment in developing new effective antibiotics. The severity of the consequences is clear to ...
Scientists have known for more than half a century that patients could develop resistance to the drugs used to treat them. Alexander Fleming, who is credited with creating the first antibiotic, penicillin, in 1928, cautioned of the impending crisis while accepting his Nobel prize in 1945: “There ...
Co-trimoxazole is a fixed-dose combination of two antimicrobial drugs (sulfamethoxazole and trimethoprim) that covers a variety of bacterial, fungal and protozoan infections. Co-trimoxazole preventive therapy is a feasible, well tolerated and inexpensive intervention for people living with HIV to re...
The internationally recognized criteria for diagnosis of neurocysticercosis include a requirement for neuroimaging techniques, such as computerized tomography (CT) and/or magnetic resonance imaging (MRI), ideally supported by serology. These facilities are not available in all settings, especially i...
Nat Commun 9, 5370 (2018). https://doi.org/10.1038/s41467-018-07804-8. Mycobacterium ulcerans is the causative agent of Buruli ulcer, a neglected tropical skin disease that is most commonly found in children from West and Central Africa. Despite the severity of the infection, therapeutic options are...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...
sthma prevalence is increasing worldwide, and surveys indicate that most patients in developed and developing countries, including South Africa, do not receive optimal care and are therefore not well controlled. Standard management guidelines adapted to in-country realities are important to support ...
Historically, the discovery of the sulfa drugs in the 1930s and the subsequent development of penicillin during World War II ushered in a new era in the treatment of infectious diseases. Infections that were common causes of death and disease in the pre-...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...
In many low- and middle-income countries, there is a wide gap between evidencebased recommendations and current practice. Treatment of major CVD risk factors remains suboptimal, and only a minority of patients who are treated reach their target levels for blood pressure, blood sugar and blood choles...
Third edition
Standard Treatment Guideline
The key updates include: content update in various sections based on new evidence; design changes for enhanced usability; a streamlined and simplified clinical assessment that includes an algorithm for follow-up; inclusion of two new modules
- Essential Care and Practice that includes general guid...
The manual is written for clinicians working at the district hospital (first-level referral care) who diagnose and manage sick adolescents and adults in resource constrained settings. It aims to support clinical reasoning, and to provide an effective clinical approach and protocols for the managemen...
Standard Treatment Guideline
